|
Originally published In Press as doi:10.1074/jbc.M203515200 on June 21, 2002
J. Biol. Chem., Vol. 277, Issue 36, 33468-33476, September 6, 2002
Sit4 Is Required for Proper Modulation of the Biological
Functions Mediated by Pkc1 and the Cell Integrity Pathway in
Saccharomyces cerevisiae*
Maria
Angeles de la Torre-Ruiz §¶,
Jordi
Torres §,
Joaquin
Ariño , and
Enrique
Herrero
From the Departament de Ciències Mèdiques
Bàsiques, Facultat de Medicina, Universitat de Lleida, Rovira
Roure 44, 25198-Lleida, Spain and the Departament de Bioquimica
i Biologia Molecular, Facultat de Veterinaria, Universitat Autonoma
de Barcelona, 08193 Bellaterra, Barcelona, Spain
Received for publication, April 11, 2002, and in revised form, May 31, 2002
 |
ABSTRACT |
Maintenance of cellular integrity in
Saccharomyces cerevisiae is carried out by the activation
of the protein kinase C-mediated mitogen-activated protein
kinase (PKC1-MAPK) pathway. Here we report that correct down-regulation
of both basal and induced activity of the PKC1-MAPK pathway requires
the SIT4 function. Sit4 is a protein phosphatase also
required for a proper cell cycle progression. We present evidence
demonstrating that the G1 to S delay in the cell cycle,
which occurs as a consequence of the absence of Sit4, is mediated by
up-regulation of Pkc1 activity. Sit4 operates downstream of the plasma
membrane sensors Mid2, Wsc1, and Wsc2 and upstream of Pkc1. Sit4
affects all known biological functions involving Pkc1, namely Mpk1
activity and cell wall integrity, actin cytoskeleton organization, and
ribosomal gene transcription.
 |
INTRODUCTION |
The Saccharomyces cerevisiae gene SIT4 codes
for a Ser/Thr protein phosphatase member of the PPP phosphatase family
that is closely related to the PP2A family (1, 2). Sit4 displays a high
level of identity to both the fission yeast phosphatase ppe1
and the human protein phosphatase 6, which are involved in cell cycle
regulation (3, 4). Sit4 participates in a number of cellular processes
such as the Tor pathway-mediated response to nutrients (5-7) and the
regulation of monovalent ion homeostasis and intracellular pH (8). Sit4
also plays an important role in cell cycle regulation, as it is
required for the proper G1 to S phase transition (9, 10).
Cells deleted for SIT4 are either nonviable or display slow
growth because of an expanded passage through G1 (9,
11-13). This delay is partly because of the role of SIT4 in
the normal transcription control of the G1 cyclin genes
CLN1 and CLN2, and also in the control of
SWI4, coding for a DNA-binding protein required for
transcriptional modulation of CLN1/CLN2 (14, 11). In
addition, SIT4 is believed to function in a pathway parallel
to CLN3 for the activation of CLN1 and
CLN2 expression through BCK2 (15).
Ppz1 and Ppz2 (16, 17) represent another subset of Ser/Thr protein
phosphatases, which play an opposite role to Sit4 in cell cycle
regulation (13). The absence of PPZ1 compensates for the
delay in cyclin accumulation and also alleviates the budding defect
observed in a sit4 mutant (13). PPZ1 has been
reportedly involved in the maintenance of cell integrity in cooperation
with the PKC1-mitogen activated protein kinase
(MAPK)1 pathway (17).
Overproduction of Ppz1 suppresses the lysis phenotype of null mutants
in PKC1 and MPK1 (17). The PKC1-MAPK pathway is a
phosphorylation cascade that responds to signals related to yeast cell
integrity, such as: mating pheromone (18), low osmolarity (19), and
high temperatures (20). Mpk1/Slt2 is the last kinase member of the
pathway. Simultaneous deletion of MPK1 and PPZ1
is lethal for the cell (17).
Cell wall stress is detected by the plasma membrane sensors Mid2 (21),
Wsc1/Hsc77/Slg1, Wsc2, and Wsc3 (22, 23), and the signal is transmitted
downstream via the GTP-binding protein Rho1 that activates the
PKC1-MAPK module (21, 22). Pkc1 phosphorylates the MAPK kinase kinase
Bck1 (24), which in turn, transmits the signal to the redundant MAPK
kinases: Mkk1 and Mkk2 (25). These finally phosphorylate the Slt2/Mpk1
MAPK (26) on both Tyr192 and Thr190 residues
(19, 27, 28) causing the activation of the kinase. Phosphorylation and
activation of Mpk1 leads to a number of cellular responses. Thus,
activation of Mpk1 results in phosphorylation of the transcriptional
factor Swi6 through which the pathway is linked to the cell cycle
regulatory machinery (29, 30). The PKC1 pathway is also involved in
budding control (18) and cell wall synthesis (21), by regulating (i)
the expression (often in a cell cycle-dependent fashion) of
several genes coding for proteins related to cell wall synthesis and
structure (31-34), and (ii) the organization of the actin cytoskeleton
(35).
Genetic evidence indicates that Ppz1/Ppz2 phosphatases act
independently of the PKC1-MAPK pathway (17). Their role therefore seems
to be different from that of other phosphatases, such as Ptp2/Ptp3 (36)
or Msg5 (37), which are known to dephosphorylate and negatively
regulate certain components of the pathway. The observation that Ppz1
and Sit4 exhibit a functional antagonism in cell cycle regulation (13)
prompted us to investigate whether this antagonism could also be
extended to the functional connection with the PKC1 pathway.
Here we demonstrate that Sit4 is required for down-regulation of Pkc1
activity, and is consequently needed for a number of functions that
depend on this kinase, such as Mpk1 activity, cytoskeleton organization, ribosomal gene expression, and cell cycle progression.
 |
MATERIALS AND METHODS |
Yeast Strains, Culture Medium, and Genetic
Methods--
The S. cerevisiae strains used in this work
are listed in Table I. Unless otherwise
stated, they are derived from either CML125 or CML128 wild type strains
(38). The following strains were obtained from their corresponding
diploids by tetrad analysis: MML200 and MML203 from MML182, MML216 from
MML185, MML231 and MML233 from MML230, and MML344 and MML345 from
MML282.
Yeast cells were usually grown in YPD medium (2% yeast extract, 1%
peptone, 2% glucose) or in the selective glucose minimal medium, SD
(0.67% yeast nitrogen base, 2% glucose, and the required amino acids)
(39). Where indicated, D-sorbitol was added to a final
concentration of 1 M. To repress expression of the
PKC1 gene under the tetO7 promoter
(40), cells were, respectively, grown in SD plus 10 µg/ml doxycycline
until early log phase, then filtered and washed in the same medium
without doxycycline. Cells were then resuspended in YPD and incubated
for 6 h at 25 °C. After that, cultures were split in two.
One-half was kept at the same temperature and the other was shifted to
37 °C for 30 min. Cells were subsequently collected by filtration
and treated for total protein extraction as described in Ref. 41.
Yeast transformations were performed as described in Ref. 42. The
MPK1 gene was disrupted using a URA3 cassette
(26). The URA3 marker from Candida albicans (43)
was used to disrupt the WSC1 gene according to the one-step
disruption method (44). This method was also employed to disrupt the
MID2, BCK1, and MSG5 genes with the
kanMX4 module and the WSC2 gene with the
natMX4 module (45).
DNA Manipulation and Plasmids--
DNA manipulation, plasmid
recovery, and bacterial transformation were performed according to
standard methods (46). Escherichia coli DH5
(Invitrogen) was used for plasmid amplification.
YEplac195-SIT4 (TRP2µ) plasmid harbors a
genomic 2.65-kb SnaBI-NheI fragment containing
the SIT4 gene cloned in the SmaI-XbaI restriction site of YEplac195 (47). Plasmid pMM66 is a YEplac195 derivative (URA3/2µ) (48) containing MSG5 under
its own promoter cloned at the SmaI vector site.
MSG5 was amplified by PCR from yeast genomic DNA. Plasmid
pMM69 is a YEplac195 derivative harboring (PCR-amplified)
PTP2 under its own promoter and cloned into the KpnI and HindIII vector sites. Plasmid pMM126 is
a pCM265 derivative (URA3/ CEN) (40) that contains
PCK1 under the tetO7 promoter and is
tagged with three copies of the HA epitope at the N terminus of the
protein. The PCK1-coding sequence was obtained from genomic DNA by PCR and directionally cloned into PmeI and
PstI vector sites (47). The pRS413-BCK1-20
plasmid is described in Ref. 24. The pMpk1-HA plasmid is a YEP352
derivative, Mpk1 ORF is cloned under its own promoter and
HA-tagged in C-terminal (a gift from Maria Molina, University
Complutense, Madrid, Spain).
Cell Synchronization--
For synchronization experiments, cells
were exponentially grown to 107 cells/ml. S and
G2 arrests were performed with hydroxyurea and nocodazole,
respectively, at the concentrations indicated in the text.
G1 arrests were performed either by -factor treatment
(10 µg/ml) or by elutriation. All cell cycle arrests were performed at 25 °C for 2 h in the case of the wild type strain and for
4 h in the case of the sit4 mutant. Cells were
elutriated according to the protocol described in Ref. 48.
Fluorescence-activated cell sorting (FACS) sample analysis (49) was
used to confirm correct synchronization.
Actin Staining--
Cells were stained with rhodamine-phalloidin
as described in Ref. 50.
Yeast Extracts and Immunoblot Analyses--
For Western
analysis, cells were collected on ice, filtered through 0.22-µ
Millipore membranes, washed with ice-cold medium, transferred to
Eppendorf tubes with 1 ml of ice-cold medium, and then centrifuged for
30 s at 13,000 rpm. Total yeast protein extracts were prepared in
ice-cold lysis buffer (75 mM Tris-HCl, pH 7.5, 0.45 M KCl, 10% glycerol, 1 mM phenylmethylsulfonyl
fluoride, 1 mM
L-1-tosylamido-2-phenylethyl chloromethyl ketone, 1 mM pepstatin, 1 mM -glycerophosphate, 1 mM EGTA, 5 mM sodium pyrophosphate, and the
protease inhibitors chymostatin, leupeptin, and antipain each at 5 nmol/µl). After the addition of SDS to a final concentration of 1%,
lysates were then boiled at 95 °C for 5 min. Equivalent amounts of
total protein extracts were run on SDS-PAGE gels with 10% acrylamide.
The anti-phospho-p44/p42 antibody (New England Biolabs) was used at a
final dilution of 1:2000 in TBST buffer. The anti-Swi6 antibody was
used at a dilution of 1:10,000 in the same buffer, and the
anti-GST-Mpk1 antibody (37, 51) at a dilution of 1:1000 in the presence
of 5% fat milk (51). Horseradish peroxidase-linked secondary
antibodies, anti-rabbit, or anti-mouse (NA931 and NA934, Amersham
Biosciences), were used at a 1:10000 dilution and incubated in
TBST buffer containing 2% fat milk for the anti-phospho-Mpk1 and
0.25% fat milk for the other two primary antibodies. Chemiluminescent
detection was performed using the Supersignal substrate (Pierce) in a
Lumi-Imager (Roche Molecular Biochemicals).
Kinase Activity--
Immunoprecipitation of Pkc1 and in
vitro protein kinase assays were performed using either myelin
basic protein (fragment 4-14, Sigma) or a Bck1-Ser939 synthetic peptide
according to Ref. 41. To inhibit Pkc1 activity, 4 × 10 9 M staurosporine was added to the kinase
reaction (52). Mpk1 immunoprecipitation and protein kinase assay were
conducted following the protocol described in Ref. 20.
 |
RESULTS |
The Absence of Sit4 Leads to a Specific Up-regulation of Slt2/Mpk1
MAP Kinase Activity--
We had previously tested Mpk1 basal and heat
shock-induced levels of activity in a ppz1 mutant and
observed that they were severely impaired (data not
shown).2 To examine whether
Mpk1 phosphorylation levels were higher in the absence in Sit4 than in
wild type cells (antagonically to that observed in the
ppz1 mutant), we used the anti-phospho-p44/42 MAPK
antibodies raised against dually phosphorylated
(Thr202/Tyr204)-p44/42 MAPK. These antibodies
allow accurate monitoring of Mpk1 activity (23, 37). Wild type and
sit4 cells were grown at 25 °C and then shifted at
37 °C for various time periods (Fig. 1A). sit4 cells
showed increased basal phosphorylation levels as compared with wild
type cells (Fig. 1A). Upon heat shock, Mpk1 phosphorylation
was much more intense in mutant than wild type cells, and remained
higher for longer periods. These changes could not be ascribed to
variations in the total amount of Mpk1 protein, as their levels
remained constant in all cases, a fact deduced by probing the same
protein samples with an anti-GST-Mpk1 antibody (Fig. 1A).
Quantification and normalization of phosphorylation levels revealed
that after 30 min of heat shock, Mpk1 phosphorylation levels in the
sit4 mutant were 10 times higher than in wild type cells
(Fig. 1B). We performed an in vitro Mpk1 kinase
assay in order confirm that the dual Mpk1 phosphorylation detected with the p44/42 antibody correlated to Mpk1 activity. As expected, we were
able to detect greater Mpk1 kinase activity levels in sit4 exponentially growing cells, both at 25 °C or
after 30 min of shifting cells at 37 °C compared with the wild type
(Fig. 1C). To prove that the increase in Mpk1 activity
observed in a sit4 strain was not because of an indirect
effect caused by the lack of this gene, we performed overexpression
analyses by using a multicopy plasmid carrying Sit4 under its own
promoter. Sit4 overexpression provoked a dramatic decrease in both the
basal and induced phosphorylation state of Mpk1 in wild type cells
(Fig. 1D), which demonstrates that Sit4 exercises specific
regulatory control over Mpk1 activity.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Mpk1 activity is up-regulated in the absence
of SIT4. A, log phase cultures of wild-type
(CML128) and sit4 cells were grown in YPD at 25 °C
(time 0) and shifted at 37 °C for the indicated periods.
Anti-phospho-p44/p42 was used to detect Mpk1 phosphorylation,
anti-Gst-Mpk1 to quantify total amounts of Mpk1 protein, and anti-Swi6
to detect the Swi6 phosphorylation state. B, histograms
represent Mpk1 phosphorylation levels relative to total Mpk1 protein
(arbitrary units) from a representative experiment, quantified using a
CCD Lumi-Imager chamber (Roche Molecular Biochemicals).
C, wild type and sit4 cells were
transformed with a multicopy plasmid carrying Mpk1 HA-tagged in
C-terminal. Samples were collected from exponentially growing cultures
either at 25 °C or after 30 min of shifting cells at 37 °C.
Histograms represent arbitrary units of Mpk1 kinase activity using
myelin basic protein as a substrate. Mpk1-HA immunoprecipitates are
shown in the inset. D, cultures from
sit4 and CML128 cells, transformed with the Yep-Sit4
multicopy plasmid, were exponentially grown in SD media plus
amino acids at 25 °C. Cultures were washed and transferred to fresh
YPD media for 4 h at 25 °C (time 0), then shifted at 37 °C
for the times indicated.
|
|
We reasoned that if Mpk1 was hyperphosphorylated in cells lacking Sit4,
this could result in biological changes derived from kinase activation.
To test this we examined the phosphorylation of Swi6 (a transcription
factor whose phosphorylation after heat shock depends on Pkc1-mediated
Mpk1 activation (29, 30, 53)).
We monitored Swi6 phosphorylation with polyclonal antibodies that
detect two forms of the protein in wild type cells: a faster migrating
band corresponding to the hypophosphorylated Swi6 state and a slower
mobility hyperphosphorylated Swi6 band. In nonstressed wild type cells
only the hypophosphorylated form was detected, and shifting the cells
to 37 °C resulted in the appearance of hyperphosphorylated Swi6
(Fig. 1A). In contrast, in sit4 cell extracts
hyperphosphorylated Swi6 was readily observed at 25 °C. Moreover,
after heat shock the proportion of this form dramatically increased
with respect to wild type cells, and remained higher throughout the
experiment (Fig. 1A). Hyperphosphorylation of Swi6 in
sit4 cells after heat shock was fully mediated by Mpk1,
as no changes in mobility were observed in a sit4 -mpk1
double mutant (data not shown). In conclusion, the above results
point to Sit4 being necessary for negative modulation of Mpk1 activity
and, consequently also for downstream processes dependent on this activity.
The Absence of Sit4 Affects Mpk1 Phosphorylation at All Phases of
the Cell Cycle and Is Not the Result of Intrinsic Cell Wall
Defects--
It could be hypothesized that the increased activation of
Mpk1 found in sit4 cells derives from intrinsic cell wall
defects in the mutant that would lead to constitutive hyperactivation of the PKC1-MAPK pathway. To test this possibility, we monitored Mpk1
phosphorylation in cells growing in the presence of 1 M
sorbitol used as an osmotic stabilizer. This condition prevented Mpk1
phosphorylation when the cell wall was severely stressed (34). Growth
in the presence of sorbitol resulted in reduced Mpk1 phosphorylation after the shift to 37 °C (Fig.
2A). However, the presence of
the stabilizer did not prevent Mpk1 basal phosphorylation in a
sit4 mutant with respect to other wild type cells.
Therefore, hyperactivation of Mpk1 in the absence of Sit4 is not a
consequence of hypothetical cell wall defects derived from the lack of
Sit4. In fact, a sit4 mutant showed increased tolerance
to treatment with zymolyase (a combination of 1,3- -glucanase and
protease enzymes that degrade the yeast cell wall) with respect to wild
type cells (Fig. 2B). In contrast, as previously described
(34) the mpk1 mutant was hypersensitive to enzymatic
digestion.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
The high Mpk1 activity in sit4
mutants is not relieved by sorbitol and does not depend on the
cell cycle stage. A, CML128 and sit4
cells were exponentially grown at 25 °C (time 0) in
YPD ± 1 M sorbitol and shifted to 37 °C.
B, cells from wild type, sit4 , and
mpk1 were cultured in YPD at 24 °C to mid-log phase
and subsequently treated with 1 unit/ml zymolyase 100T for the
indicated times, according to de Nobel et al. (34). Cell
lysis was estimated by measuring A600. Values
represent the average of three independent experiments.
C, cultures from wild type and sit4 cells
were exponentially grown at 25 °C (time 0) in YPD medium
and synchronized at different stages of the cell cycle: in
G1 with 10 µg/ml -factor, in S phase with 200 µg/ml
HU (hydroxyurea), and in G2 with 10 µg/ml nocodazole
(NOC). Following treatments, cultures were shifted from 25 to 37 °C. In all cases, arrest was maintained throughout the
experiment. D, cells from wild type and
sit4 log-phase cultures were elutriated in G1
as described under "Materials and Methods." After collection, cells
were transferred to fresh YPD medium at 25 °C and allowed to
progress up to the second cell cycle. Immunoblot analyses using
anti-Swi6, anti-phospho-p44/p42 (bands shown in the figure), and
anti-GST-Mpk1 were performed as described in the legend to Fig 1. In
all cases, we made a parallel Western blot using the same samples to
quantify the total amount of Mpk1 with anti-GST-Mpk1 antibody and
confirmed that equal levels of this protein were detected in all lines
(data not shown).
|
|
Exponentially growing cultures of sit4 are enriched in
G1 cells, and it has been reported that Mpk1 becomes
phosphorylated at the G1/S transition in a cell
cycle-dependent manner (18). Increased Mpk1
dual-phosphorylation in a sit4 mutant could therefore result from the presence of a higher proportion of cells in
G1 in asynchronous cultures. To discard this possibility,
we performed heat-shock experiments with cells synchronized with
-factor in G1, in S with hydroxyurea, and in
G2 with nocodazole. In all three cases basal and
heat-induced Mpk1 phosphorylation were higher in sit4
than in wild type cells (Fig. 2C). As these treatments are
somewhat stressful for cells and might affect Mpk1 phosphorylation, G1 small daughter cells were recovered by elutriation, and
allowed to progress through the cell cycle, to monitor Mpk1
phosphorylation. At all tested time points, Mpk1 phosphorylation in
sit4 cells was more intense than in wild type cells (Fig.
2D). It can therefore be concluded that the absence of Sit4
affects Mpk1 phosphorylation regardless of its position in the cycle.
This also demonstrates that the higher activity detected in
sit4 cells is not merely a circumstantial effect caused
by the partial synchronization in G1 in this mutant.
Sit4 Functions Upstream of Pkc1 and Negatively Regulates Its
Activity--
We constructed pkc1 -sit4 and
bck1 -sit4 double mutants to investigate whether the
induction of Mpk1 activity that occurs in the absence of Sit4 was
dependent on Pkc1. However, neither Mpk1 phosphorylation nor Swi6
hyperphosphorylation were observed in pkc1 -sit4 (Fig.
3A, and data not shown) or
bck1 ,sit4 (not shown) double mutants at 25 or
37 °C. We conclude that an intact PKC1-MAPK module is required for
the Mpk1 activation caused by the absence of Sit4 function. This points
against Sit4 defining a Mpk1-inactivating pathway independent from
Pkc1.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 3.
Sit4 is not epistatic to the
PKC1-MAP pathway, and functions upstream of Pkc1 in
the modulation of the pathway activity. A, mid-log
cultures from wild type, sit4 -pkc1 , and
sit4 -pkc1 strains growing at 25 °C were shifted to
37 °C for 30 min. B, exponential cultures of the
following strains at 25 °C: sit4 /pBCK1-20,
sit4 -pkc1 /pBCK1-20,
pkc1 /pBCK1-20, and CML128/pBCK1-20 were grown as
described in the legend to Fig. 2 and samples were taken at
25 °C for Western blot. Asterisk represent values
corresponding to the amount of phosphorylated Mpk1 relative to total
GST-Mpk1 protein for each strain. C, wild type and
sit4 cells were transformed with a plasmid carrying the
Pkc1-HA-tagged protein under the control of the
tetO7 promoter. Growth conditions and protein
preparation are described under "Materials and Methods." Histograms
represent arbitrary units of Pkc1 kinase activity using two different
Pkc1 substrates. Pkc1-HA immunoprecipitates are shown in the
inset. St, staurosporine. Schematic representation of some
of the elements of the cell integrity pathway used in this study.
D, mid-log cultures from sit4 , wild type,
wsc1 , sit4 -wsc1 , mid2 , and
sit4 -mid2 strains growing at 25 °C were shifted at
37 °C for 30 min. E, mid-log cultures from
sit4 , wild type, sit4 -wsc1 -wsc2 ,
wsc1 -wsc2 , sit4 -wsc1 -mid2 , and
wcs1 -mid2 strains growing at 25 °C were shifted at
37 °C for 30 min. F, exponentially growing wild
type, bem2 -sit4 , and bem2 cells at
25 °C ( ) were shifted to 37 °C for 30 min (+). Equal amounts of
total protein extracts were loaded onto SDS-polyacrylamide gels and
subsequently immunoblotted with the anti-phospho-p44/p42 antibody.
Except in part C, the bands shown in the figure correspond
to phospho-Mpk1. The levels of total Mpk1 detected with the
anti-GST-Mpk1 antibody were similar in each sample (data not
shown).
|
|
We followed two different approaches to functionally situate Sit4 with
respect to Pkc1. First, we used a BCK1-20 allele that constitutively activates Mpk1 (24). We transformed the
PKC1/pkc1 SIT4/sit4 diploid strain using a plasmid
bearing the BCK1-20 allele. After sporulation, the
pkc1 ,sit4 , pkc1 , and sit4
strains (bearing the pBCK1-20 plasmid) were isolated and Mpk1
phosphorylation was subsequently analyzed. It is important to stress
that after heat shock Mpk1 still became hyperactivated in the presence
of a BCK1-20 allele (not shown). Our reasoning was
therefore as follows: if Sit4 acts downstream of Pkc1 as a negative
regulator for the pathway, then both sit4 /pBCK1-20 and
pkc1 -sit4 /pBCK1-20 cells would exhibit higher levels
of Mpk1 activity than wild type and pkc1 cells
transformed with pBCK1-20, respectively. Alternatively, if Sit4 acts
upstream of Pkc1 we would first expect the constitutive phosphorylation
level of Mpk1 in sit4 /pBCK1-20 cells to be higher than
in any of the other strains tested, and second we would expect pkc1 -sit4 /pBCK1-20 and pkc1 /pBCK1-20
cells to exhibit the same constitutive levels of Mpk1 activity,
revealing that in the absence of Pkc1 the lack of Sit4 would have no
effect on Mpk1 phosphorylation. In fact, and as predicted by the second
hypothesis, in pkc1 -sit4 /pBCK1-20 and
pkc1 /pBCK1-20 strains, the constitutive activity of Mpk1 was lower than that observed in wild type/pBCK1-20 cells. We also observed that the absence of Sit4 together with the presence of the
BCK1-20 allele had an additive effect on basal levels of
Mpk1 activity (Fig. 3B). However, this
sit4 -mediated additive effect was suppressed when
PKC1 was deleted. This suggested that up-regulation of Mpk1
phosphorylation in sit4 /pBCK1-20 cells was the result of
two independent processes, one because of constitutive Mpk1 activation
caused by the BCK1-20 allele and the other because of
up-regulation of Pkc1 activity in the absence of Sit4. These results
support the hypothesis that situates Sit4 upstream of Pkc1. To confirm
this, in a second approach we sought to determine Pkc1 kinase activity
using two different substrates. In both, wild type and
sit4 cells were transformed with a centromeric plasmid
bearing the Pkc1-HA-tagged protein under control of a regulatable
tet promoter (40). We obtained the same results with both
substrates: basal activity was barely detectable. However, Pkc1
activity induced after heat shock was much higher in sit4 than in wild type cells, and was suppressed after the addition of the
Pkc1 inhibitor staurosporine (Fig. 3C). These results
confirmed that Sit4 is required to negatively modulate Pkc1 activity in the cell integrity pathway.
We next studied Mpk1 phosphorylation in mutants lacking SIT4
and WSC1, WSC2, or MID2 plasma
membrane receptor genes. In the case of both
sit4 -wsc1 , and the sit4 -mid2 double
mutants, Mpk1 phosphorylation was markedly more induced than in
wsc1 -mid2 , and wild type cells at the respective
temperatures (Fig. 3D). To simplify the figure we did not
include the results obtained with the wsc2 mutant as they
were similar to those obtained with wsc1 . To ascertain
whether Sit4 is a regulator of more than one cell wall receptor (this
could explain why we were unable to detect such a regulation when using
single mutants), we constructed the wsc1 -wsc2 and
wsc1 -mid2 double mutants and corresponding triple mutants in combination with sit4 . Again, in both
wsc1 -wsc2 -sit4 and
wsc1 -mid2 -sit4 triple mutants, both basal and
induced Mpk1 activity was higher in wild type cells and double mutants,
and was equivalent to the Mpk1 phosphorylation levels observed in the
sit4 strain (Fig. 3E). Bem2 is a GTPase
activating protein that down-regulates Rho1 (54). Recent proteomic
studies have shown that Bem2 and Sit4 along with other proteins form
part of the same protein complex (55). Because both basal and induced Mpk1 activity are increased in bem2 compared with wild
type cells (37), we wondered whether Sit4 might be regulating Bem2
activity. We observed that in the sit4 -bem2 double
mutant there was an additive effect in the increase of basal Mpk1
(2.5-fold) and heat shock-induced phosphorylation (2-fold) with respect
to both single mutants (Fig. 3F). This result discards the
possibility of Sit4 being a regulator for Bem2 GTPase. Taken together,
these results suggest that Sit4 operates downstream of Mid2, Wsc1, and
Wsc2 membrane receptors, independently of Bem2 and upstream from Pkc1.
The Absence of Sit4 Stimulates Transient Heat Shock-induced
PKC1-dependent Actin Cytoskeleton Depolarization--
Heat
shock induces transient depolarization of the actin cytoskeleton (56,
57) mediated by upper cell integrity pathway components
WSC1 and ROM2 (22). Rho1 and Pkc1
hyperactivation also induces depolarization of the actin cytoskeleton
in the absence of heat stress (22). We examined actin polarization in
both wild type and sit4 cells to determine whether Sit4
was also involved in the regulation of this process. Both wild type and
sit4 cells showed normal actin distribution at 25 °C,
whereas random actin disorganization occurred after 30 min at 37 °C.
However, whereas normal actin distribution was restored in wild type
cells after 90 min, in the case of the sit4 mutant this
was only achieved 3 h after heat shock (Fig.
4). This effect could be explained by the
fact that Pkc1 activity after heat shock is greater in a
sit4 mutant and remains greater for longer than in wild
type cells (data not shown). The actin defect observed in
sit4 cells was not because of the slow growth rate
described for this mutant, because in the double mutant
sit4 -ppz1 , in which the cell cycle defect caused by
the absence of Sit4 was largely relieved (13), the actin cytoskeleton
remained depolarized long after heat shock as in sit4
cells (data not shown). We conclude from these results that Sit4 also
affects another known Pkc1 function, namely the transient
depolarization of the actin cytoskeleton that occurs after
environmental stress.

View larger version (81K):
[in this window]
[in a new window]
|
Fig. 4.
Sit4 was required for
Pkc1-dependent normal depolarization of the actin
cytoskeleton. Wild type (CML128) and sit4
cells were grown in rich medium at 25 °C, shifted at
37 °C for the indicated times to be fixed, and then processed for
actin cytoskeleton visualization.
|
|
Sit4 Also Regulates the PCK1 Function Required for Transcriptional
Repression of Ribosomal Genes--
Transcriptional repression of
ribosomal proteins (RP) after alteration of the yeast secretory pathway
requires Pkc1 but not Mpk1 activity (58). We studied the
transcriptional levels of the RPL30 and RPL6A
ribosomal genes in sit4 and wild type cells to test
whether this process was also affected by Sit4 function. We shifted
sit4 and wild type cultures from 25 at 37 °C for half an hour to maximize the differences in Pkc1 activity between
sit4 and wild type cells (see Fig. 1). We then treated or
mock treated cells with tunicamycin to block their secretory machinery
and took samples at various time intervals. It has been reported that Pkc1 is not required for repression of ribosomal mRNA after a heat
shock, and that this repression occurs via a different pathway than
that responding to a secretory defect (59). In accordance with this
theory, no significant differences were observed in relative levels of
RPL30 and RPL6A mRNAs or between
sit4 and wild type cells after 30 min at 37 °C (Fig.
5), despite the large differences in Pkc1
activity reflected in Mpk1 phosphorylation (Fig. 1A).
However, upon addition of tunicamycin, RP relative mRNA levels
decreased significantly faster in sit4 than in wild type
cells (Fig. 5, A and B), although with no
apparent changes in ACT1 and U1 mRNA levels
(data not shown). Nevertheless in mock treated cells mRNA levels
showed a significant increase after heat shock that was maintained
throughout the experiment (Fig. 5, C and D), in
accordance with Ref. 59. Using anti-invertase polyclonal
antibodies we could not detect differences in the invertase accumulation between wild type and sit4 cultures (data
not shown) by Western blot, which indicates that the results shown
above were not a reflection of intrinsic problems in secretion in the sit4 mutant. The lack of RP mRNA repression observed
in a pkc1 mutant, under conditions in which the secretory
pathway was altered by tunicamycin, was also observed in the
sit4 pkc1 double mutant (data not shown), which means
that in the absence of Sit4, Pkc1 activity was still required for this
response. The greater RP mRNA repression observed in
sit4 cells is therefore a Pkc1-dependent response to secretory problems. Our data indicate that Sit4 is also
needed in a signaling process leading to ribosomal gene expression and
that this is dependent on Pkc1 activity but not on downstream elements
of the MAP kinase pathway.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Ribosomal gene expression upon alteration of
the secretory pathway is also affected by the absence of Sit4.
CML128 and sit4 cells were grown exponentially in YPD at
25 °C, then shifted to 37 °C for 30 min (time 0). After that,
cultures were either treated with 2.5 µg/ml tunicamycin (A
and B) or mock treated (C and D).
Relative mRNA levels obtained at time 0 were assigned the value 1, the rest of the mRNA relative levels obtained in the subsequent 3-h
experiment were normalized with respect to this value. Error
bars represent standard deviations calculated from three
independent experiments.
|
|
Pkc1 Is Involved in the G1 to S Delay Observed in the
Absence of Sit4--
As previously reported, cells lacking Sit4
display a marked defect in the G1 to S progression through
the cell cycle (Ref. 9 and Fig.
6B), which results in slower
growth compared with wild type cells (Fig. 6C).
Interestingly, when we overexpressed Pkc1 under the tet
promoter we induced an extended G1 phase in wild type (Fig.
6A) and sit4 (not shown) cultures that
provoked an increase in generation time in both strains. This was
reflected in the accumulation of cells at G1 in
exponentially growing cultures (Fig. 6A), which resembled
sit4 FACS profiles. This delay in G1 was also
observed when we overexpressed the constitutively active allele
PKC1(R398A,R405A,K406A) under the Gal promoter (not shown). Pkc1 overexpression also provoked an increase in Mpk1 activity
(Fig. 6A). Given the correlation observed between Mpk1 basal
activity and G1 delay between the sit4 mutant
and cells overexpressing Pkc1, we speculated that high levels of
PKC1-MAPK activity would induce a G1 delay. This could
explain why, in the absence of Sit4, the cell cycle was extended in
G1, in comparison with wild type cells. Following this line
of reasoning, we would expect sit4 cells not to display a
G1 defect in the absence of Pkc1. As shown in Fig.
7B, pkc1
deletion efficiently suppressed the accumulation of cells in
sit4 cultures at G1. In all cases, cells were
grown in rich medium plus the osmotic stabilizer sorbitol (1 M) to prevent cell lysis because of the absence of Pkc1. In support to this, sit4 -pkc1 and also pkc1
populations displayed similar generation times of about 180 min at
25 °C growing in rich medium plus sorbitol, very similar to
that of wild type cells (Fig. 6C). Even so, the
sit4 cells doubling time was twice as long as that
observed in the above mentioned cultures. This phenotype must be
specific to Pkc1 because the absence of Mpk1 did not rescue the
G1 defect because of the absence of Sit4 function (Fig. 6, B and C). This is not strange since not all Pkc1
functions are mediated by Mpk1. We conclude from these results that
high PKC1-MAPK activity induces a delay in the G1 to S
phase progression, and that the G1 delay that occurs in the
absence of Sit4 would be mediated by Pkc1.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
Pkc1 overexpression induces a G1
arrest. A, cultures of CML128 and CML128 harboring
a plasmid with Pkc1 under the tetO7 promoter
were grown in minimum medium to log phase, then washed several times to
eliminate doxycycline to induce Pkc1 expression (see "Materials and
Methods"). Samples were taken at the indicated periods for FACS
analyses and Western blot. B, FACS profiles of the
indicated strains grown exponentially at 25 °C in YPD + 1 M sorbitol. C, serial dilutions of CML128,
sit4 , pkc1 , sit4 -pkc1 ,
mpk1 , and sit4 -mpk1 exponentially
growing cultures in YPD plus 1 M sorbitol.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 7.
Schematic model of the down-regulatory effect
that Sit4 exercises on Pkc1 biological functions. These are: actin
cytoskeleton organization, ribosomal gene transcription, cell cycle
regulation at G1, and Mpk1 basal and induced activity that
results in the subsequent activation of a number of cellular responses
to cell wall stress, including transcriptional induction of genes
involved in cell-wall repair. Whether Swi6 phosphorylation signals the
latter process remains unclear. The function we attribute to Sit4 can
probably be exerted through regulation of various elements termed
X, which in turn directly interacts with Pkc1. Candidates
for this are the known and/or unknown upstream elements of the
PKC1-MAPK pathway (cell wall receptors, GTP-exchange factors,
GTPase activating proteins, or G-proteins).
|
|
 |
DISCUSSION |
One major finding of this study is that Sit4, a phosphatase whose
function has been related to cell cycle control and nutritional state,
is also involved in the functional regulation of the Pkc1 pathway. Sit4
functions upstream of Pkc1 and components of the PKC1-MAPK cascade, but
downstream of the Wsc1, Wsc2, and Mid2 plasma membrane receptors, and
the latter signal changes in cell wall integrity to Pkc1 via Rom2 and
Rho1 (60). We also present evidence demonstrating that for this
function Sit4 also acts independently of Bem2 (a GTPase-activating
protein which regulates Rho1). The role of Sit4 in the modulation of
the pathway is reflected in: (i) maintenance of a normal/basal level of
Mpk1 activity throughout the cell cycle, and (ii) down-regulation the
PKC1-MAPK module once this has been activated by external signals that
affect cell membrane integrity, such as heat shock. Therefore, two
biological processes that depend on Pkc1 activity via Mpk1 are affected
by Sit4: phosphorylation of Swi6, and basal expression of
FKS1 (data not shown) involved in cell wall assembly (31,
33). Little is known about the role that Pkc1-dependent
Swi6 phosphorylation exercises in the cellular processes after heat
shock, although it is known that Swi6 is required for
Pkc1-dependent transcriptional induction of some cell wall
genes after heat shock (31). In addition, it has been reported that
heat shock and osmotic stress cause cells to transitorily accumulate at
G1, which correlates with a descent in the transcription of
G1 cyclin genes CLN1 and CLN2 (61,
62). However, no clear relationship was observed between Swi6
phosphorylation after heat shock and cyclin expression, either in
sit4 or in wild type cells (data not shown).
Another major novel finding addressed in this study is the observation
that Pkc1 overexpression and activation of the pathway induce a
prolonged G1 phase in exponentially growing cultures. This
function might help to explain the G1 to S defect observed in sit4 mutants (14, 13), because such a defect is
rescued to wild type levels in a sit4 -pkc1 double
mutant. Furthermore, the fact that the absence of Mpk1 does not
compensate for the sit4 growth defect suggests that the
functional interaction between Sit4 and Pkc1 in G1 cell
cycle regulation is specific to Pkc1 activity. Therefore, the
G1 delay as a consequence of the absence of Sit4 function
is mediated by the up-regulation of Pkc1 activity. Pkc1-mediated cell
cycle regulation is not a trivial matter, because overexpression of
CLN2, which shortens the G1 phase, does not compensate for the greater Mpk1 activity observed in the
mutant.2 Future studies will contribute to clarify this function.
We have also addressed the question of whether the high levels of Pkc1
and Mpk1 activity observed in sit4 cells were merely a
direct consequence of intrinsic cell wall problems. This is apparently
not the case, as osmotic stabilization of the cell wall does not
suppress up-regulation of Mpk1 activity. On the contrary, the
observation that this mutant displayed a cell wall more resistant to
zymolyase digestion could reflect two processes: (i) an up-regulation
of Rho1 in the absence of Sit4 that could lead to greater Fks1
activity, and (ii) an increase in cell wall gene expression mediated by
greater Mpk1 activity. Our unpublished observations2 show
that Sit4 is functionally independent from the Ptp2 and Msg5 protein
phosphatases, and that these directly down-regulate Mpk1 activity (36,
37).
BCK2 is a suppressor of the lethality caused by mutations in
the cell integrity pathway (27), and is also involved in the SIT4 pathway for CLN activation (15). This raised
the possibility of a functional relationship between BCK2
and SIT4 in controlling the activity in the PKC1-MAPK
pathway. However, BCK2 does not act in the same pathway as
SIT4 for this function, because the kinetics of Mpk1
phosphorylation in bck2 cells are very similar to those
of wild type cells.2
The location of Sit4 upstream of Pkc1 in the cell integrity pathway led
us to hypothesize that it could contribute to the modulation of other
Pkc1-dependent biological processes that are not directly
regulated by Mpk1. Pkc1 plays a role in the organization of the actin
cytoskeleton but apparently does not depend on Mpk1 (22). Heat shock
stress induces a transient depolarization of actin patch distribution
in the cytoplasm. This process, and the subsequent repolarization of
actin, both depend on Pkc1, although only the latter could also be
mediated by Mpk1 (22). The observation that in the absence of
functional Sit4 the actin cytoskeleton remains depolarized for longer
periods than in wild type cells is another indication of the functional
connection between Pkc1 and Sit4 and in turn correlates to higher
levels of Pkc1 activity in the absence of Sit4.
Transcriptional repression of ribosomal genes upon impairment of the
secretory machinery is also dependent on Pkc1, but independent of
downstream elements of the pathway (58). This process is also affected
in sit4 cells, which again supports the model in which
the absence of Sit4 would affect a number of biological processes
acting through Pkc1 both in a Mpk1-dependent and
independent way. All these results are summarized in Fig. 7.
Pph22, a type 2A protein phosphatase, has been reported as having a
positive role in cell wall integrity and cytoskeleton organization
(63). Glc7, a catalytic subunit of type 1 protein serine/threonine
phosphatases, functions positively to Pkc1 in promoting cell integrity
and polarization of the actin cytoskeleton (64). However, Sit4 is the
only phosphatase, described to date, whose role in PKC1-MAPK modulation
would produce a negative modulation upstream of Pkc1.
Sit4 is a phosphatase by sequence, and it is generally accepted that it
influences the phosphorylation of a number of substrates. However,
there is no evidence of active dephosphorylation of such substrates by
Sit4, because no specific biochemical assay for this protein has
yet been published.
Cell integrity pathway activity is necessary for survival. However, if
this pathway were not shut down when not required, a number of
processes such as cell cycle, cytoskeleton organization, and gene
transcription, among others, would be deregulated and this would affect
cell growth and viability. In this regard, Sit4 could contribute to
maintaining correct physiological levels of PKC1-MAPK activity in
cells. Further studies are needed to characterize the direct
substrate(s) on which Sit4 operates.
 |
ACKNOWLEDGEMENTS |
We are grateful to C. Di Como for reading and
commenting on the manuscript, Noel Lowndes for providing the anti-Swi6
polyclonal antibody, and Maria Molina for helpful suggestions and for
providing the anti-GST-Slt2 antibody. We also thank Luis Rodriguez for
providing the anti-invertase antibody, C. Mann and J. Clotet for
strains and plasmids, Lidia Piedrafita for excellent technical
assistance, and all the laboratory members for their advice and
valuable comments.
 |
FOOTNOTES |
*
This work was supported by Grants SGR99/00/70 from
Generalilat de Catalunya and PB97-1456 from Ministerio de
Educación y Cultura (to E. H.) and PB98-0565-C4-02 from
Ministerio de Educación y Cultura (to J. A.), a Spanish
Ministerio de Educación y Cultura postdoctoral contract
(to M. A. T. R.), and a Generalitat de Catalunya fellowship (to J. T. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Both authors contributed equally to this work.
¶
To whom correspondence should be addressed. E-mail:
madelatorre@cmb.udl.es.
Published, JBC Papers in Press, June 21, 2002, DOI 10.1074/jbc.M203515200
2
M. A. de la Torre-Ruiz, J. Torres, J. Ariño, and E. Herrero, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
MAPK, mitogen-activated protein kinase;
HA, hemagglutinin;
FACS, fluorescence
activated cell sorter;
RP, ribosomal proteins.
 |
REFERENCES |
| 1.
|
Arndt, K. T.,
Styles, C. A.,
and Fink, G. R.
(1989)
Cell
56,
527-5371[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Doseff, A. I.,
and Arndt, K. T.
(1995)
Genetics
141,
857-871[Abstract]
|
| 3.
|
Shimanuki, M.,
Kinoshita, N.,
Ohkura, H.,
Yoshida, T.,
Toda, T.,
and Yanagida, M.
(1993)
Mol. Biol. Cell.
4,
303-313[Abstract]
|
| 4.
|
Bastians, H.,
and Ponsting, H.
(1996)
J. Cell Sci.
109,
2865-2874[Abstract]
|
| 5.
|
Di Como, C. J.,
and Arndt, K. T.
(1996)
Genes Dev.
10,
1904-1916[Abstract/Free Full Text]
|
| 6.
|
Beck, T.,
and Hall, M. N.
(1999)
Nature
402,
689-692[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Jiang, Y.,
and Broach, J. R.
(1999)
EMBO J.
18,
2782-2792[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Masuda, C. A.,
Ramírez, J.,
Peña, A.,
and Montero-Lomelí, M.
(2000)
J. Biol. Chem.
40,
30957-30961[CrossRef]
|
| 9.
|
Sutton, A.,
Inmanuel, D.,
and Arndt, K. T.
(1991)
Mol. Cell. Biol.
11,
2133-2148[Abstract/Free Full Text]
|
| 10.
|
Mann, D. J.,
Dombradi, V.,
and Cohen, P. T.
(1993)
EMBO J.
12,
4833-4842[Medline]
[Order article via Infotrieve]
|
| 11.
|
Di Como, C. J.,
Bose, R.,
and Arndt, K. T.
(1995)
Genetics
139,
95-107[Abstract]
|
| 12.
|
Sutton, A.,
and Freiman, R.
(1997)
Genetics
147,
57-71[Abstract]
|
| 13.
|
Clotet, J.,
Garí, E.,
Aldea, M.,
and Ariño, J.
(1999)
Mol. Cell. Biol.
19,
2408-2415[Abstract/Free Full Text]
|
| 14.
|
Fernandez-Sarabia, M. J.,
Sutton, A.,
Zhong, T.,
and Arndt, K. T.
(1992)
Genes Dev.
6,
2417-2428[Abstract/Free Full Text]
|
| 15.
|
Di Como, C. J.,
Chang, H.,
and Arndt, K. T.
(1995)
Mol. Cell. Biol.
15,
1835-1846[Abstract]
|
| 16.
|
Posas, F.,
Casamayor, A.,
Morral, N.,
and Ariño, J.
(1992)
J. Biol. Chem.
267,
11734-11740[Abstract/Free Full Text]
|
| 17.
|
Lee, K. S.,
Hines, L. K.,
and Levin, D. E.
(1993)
Mol. Cell. Biol.
13,
5843-5853[Abstract/Free Full Text]
|
| 18.
|
Zarzov, P.,
Mazzoni, C.,
and Mann, C.
(1996)
EMBO J.
15,
83-91[Medline]
[Order article via Infotrieve]
|
| 19.
|
Davenport, K. R.,
Sohaskey, M.,
Kamada, Y.,
Levin, D. E.,
and Gustin, M. C.
(1995)
J. Biol. Chem.
270,
30157-30161[Abstract/Free Full Text]
|
| 20.
|
Kamada, Y.,
Jung, U. S.,
Piotrowski, J.,
and Levin, D. E.
(1995)
Genes Dev.
9,
1559-1571[Abstract/Free Full Text]
|
| 21.
|
Ketela, T.,
Green, R.,
and Bussey, H.
(1999)
J. Bacteriol.
181,
3330-3340[Abstract/Free Full Text]
|
| 22.
|
Delley, P. A.,
and Hall, M. N.
(1999)
J. Cell Biol.
147,
163-174[Abstract/Free Full Text]
|
| 23.
|
Verna, J.,
Lodder, A.,
Lee, K.,
Vagts, A.,
and Ballester, R.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
13804-13809[Abstract/Free Full Text]
|
| 24.
|
Lee, K. S.,
and Levin, D. E.
(1992)
Mol. Cell. Biol.
12,
172-182[Abstract/Free Full Text]
|
| 25.
|
Irie, K.,
Takase, M.,
Lee, K. S.,
Levin, D. E.,
Araki, H.,
Matsumoto, K.,
and Oshima, Y.
(1993)
Mol. Cell. Biol.
13,
3076-3083[Abstract/Free Full Text]
|
| 26.
|
Torres, L.,
Martin, H.,
Garcia-Saez, M. I.,
Arroyo, J.,
Molina, M.,
Sánchez, M.,
and Nombela, C.
(1991)
Mol. Microbiol.
5,
2845-2854[Medline]
[Order article via Infotrieve]
|
| 27.
|
Lee, K. S.,
Irie, K.,
Gotoh, Y.,
Watanabe, Y.,
Araki, H.,
Nishida, E.,
Matsumoto, K.,
and Levin, D. E.
(1993)
Mol. Cell. Biol.
13,
3067-3075[Abstract/Free Full Text]
|
| 28.
|
Lim, Y. M.,
Tsuda, L.,
Inoue, Y. H.,
Irie, K.,
Adachi-Yamada, T.,
Hata, M.,
Nishi, Y.,
Matsumoto, K.,
and Nishida, Y.
(1997)
Genetics
146,
263-273[Abstract]
|
| 29.
|
Sidorova, J. M.,
Mikesell, G. E.,
and Breeden, L. L.
(1995)
Mol. Biol. Cell
6,
1641-1658[Abstract]
|
| 30.
|
Madden, K.,
Sheu, Y. J.,
Baetz, K.,
Andrews, B.,
and Snyder, M.
(1997)
Science
275,
1781-1784[Abstract/Free Full Text]
|
| 31.
|
Igual, J. C.,
Johnson, A. L.,
and Johnston, L. H.
(1996)
EMBO J.
15,
5001-5013[Medline]
[Order article via Infotrieve]
|
| 32.
|
Zhao, C.,
Jung, U. S.,
Garret-Engele, P.,
Roe, T.,
Cyert, M. S.,
and Levin, D. E.
(1998)
Mol. Cell. Biol.
18,
1013-1022[Abstract/Free Full Text]
|
| 33.
|
Jung, U. S.,
and Levin, D. E.
(1999)
Mol. Microbiol.
34,
1049-1057[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
de Nobel, H.,
Ruiz, C.,
Martin, H.,
Morris, W.,
Bru, S.,
Molina, M.,
and Klis, F. M.
(2000)
Microbiology
146,
2121-2132[Abstract/Free Full Text]
|
| 35.
|
Helliwell, S. B.,
Schmidt, A.,
Ohya, Y.,
and Hall, M. N.
(1998)
Curr. Biol.
8,
1211-1214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Mattison, C. P.,
Spencer, S. S.,
Kresge, K. A.,
Lee, J.,
and Ota, I. M.
(1999)
Mol. Cell. Biol.
19,
7651-7660[Abstract/Free Full Text]
|
| 37.
|
Martín, H.,
Rodriguez-Pachón, J. M.,
Ruiz, C.,
Nombela, C.,
and Molina, M.
(2000)
J. Biol. Chem.
14,
1511-1519[CrossRef]
|
| 38.
|
Kaiser, C.,
Michaelis, S.,
and Mitchell, A.
(1994)
Methods in Yeast Genetics
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 39.
|
Gallego, C.,
Garí, E.,
Colomina, N.,
Herrero, E.,
and Aldea, M.
(1997)
EMBO J.
16,
7196-7206[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Garí, E.,
Piedrafita, L.,
Aldea, M.,
and Herrero, E.
(1997)
Yeast
13,
837-848[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Watanabe, M.,
Chen, C. Y.,
and Levin, D. E.
(1994)
J. Biol. Chem.
269,
16829-16836[Abstract/Free Full Text]
|
| 42.
|
Gietz, R. D., St.,
Jean, A.,
Woods, R. A.,
and Schiestl, R. H.
(1992)
Nucleic Acids Res.
220,
1425
|
| 43.
|
Goldstein, A. L.,
Pan, X.,
and McCusker, J. H.
(1999)
Yeast
15,
507-511[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Wach, A.,
Brachat, A.,
Pohlmann, R.,
and Philippsen, P.
(1994)
Yeast
10,
1793-1808[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Goldstein, A. L.,
and McCusker, J. H.
(1999)
Yeast
15,
1541-1553[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1989)
Current Protocols in Molecular Biology
, Wiley-Interscience, New York
|
| 47.
|
Gietz, R. D.,
and Sugino, A.
(1988)
Gene (Amst.)
74,
527-534[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Johnston, L. H.,
and Hohnson, A. L.
(1997)
Methods Enzymol
283,
342-350[Medline]
[Order article via Infotrieve]
|
| 49.
|
Nash, R.,
Tokiwa, G.,
Anand, S.,
Erickson, K.,
and Futcher, A. B.
(1988)
EMBO J.
7,
4335-4346[Medline]
[Order article via Infotrieve]
|
| 50.
|
Pringle, J. R.,
Adams, A. E. M.,
Drubin, D. G.,
and Haarer, B. K.
(1991)
Methods Enzymol.
194,
565-602[Medline]
[Order article via Infotrieve]
|
| 51.
|
Martín, H.,
Arroyo, J.,
Sánchez, M.,
Molina, M.,
and Nombela, C.
(1993)
Mol. Gen. Genet.
241,
177-184[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Antonsson, B.,
Montessuit, S.,
Friedli, L.,
Payton, M. A.,
and Paravicini, G.
(1994)
J. Cell Biol.
269,
16821-16828
|
| 53.
|
Sheu, Y. J.,
Santos, B.,
Fortin, N.,
Costigan, C.,
and Snyder, M.
(1998)
Mol. Cell. Biol.
18,
4053-4059[Abstract/Free Full Text]
|
| 54.
|
Wang, T.,
and Bretscher, A.
(2000)
Mol. Biol. Cell
6,
1011-1024
|
| 55.
|
Gavin, A. C.,
Bosche, M.,
Krause, R.,
Grandi, P.,
Marzioch, M.,
Bauer, A.,
Schultz, J.,
Rick, J. M.,
Michon, A. M.,
Cruciat, C. M.,
Remor, M.,
Hofert, C.,
Schelder, M.,
Brajenovic, M.,
Ruffner, H.,
Merino, A.,
Klein, K.,
Hudak, M.,
Dickson, D.,
Rudi, T.,
Gnau, V.,
Bauch, A.,
Bastuck, S.,
Huhse, B.,
Leutwein, C.,
Heurtier, M. A.,
Copley, R. R.,
Edelmann, A.,
Querfurth, E.,
Rybin, V.,
Drewes, G.,
Raida, M.,
Bouwmeester, T.,
Bork, P.,
Seraphin, B.,
Kuster, B.,
Neubauer, G.,
and Superti-Furga, G.
(2002)
Nature
415,
123-124[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Chowdhury, S.,
Smith, K. W.,
and Gustin, M. C.
(1992)
J. Cell Biol.
118,
561-571[Abstract/Free Full Text]
|
| 57.
|
Lillie, S. H.,
and Brown, S. S.
(1994)
J. Cell Biol.
125,
825-842[Abstract/Free Full Text]
|
| 58.
|
Li, Y.,
Moir, R. D.,
Sethy-Coraci, I. K.,
Warner, J. R.,
and Willis, I. M.
(2000)
Mol. Cell. Biol.
20,
3843-3851[Abstract/Free Full Text]
|
| 59.
|
Li, Y.,
Moir, R. D.,
Sethy-Coraci, I. K.,
Warner, J. R.,
and Willis, I. M.
(2000)
Mol. Cell. Biol
20,
3843-3851[Abstract/Free Full Text]
|
| 60.
|
Philip, B.,
and Levin, D. E.
(2001)
Mol. Cell. Biol.
21,
271-280[Abstract/Free Full Text]
|
| 61.
|
Rowley, A.,
Johnston, G. C.,
Butler, B.,
Werner-Washburne, M.,
and Singer, R. A.
(1993)
Mol. Cell. Biol.
13,
1034-1041[Abstract/Free Full Text]
|
| 62.
|
Bellí, G.,
Garí, E.,
Aldea, M.,
and Herrero, E.
(2001)
Mol. Microbiol.
39,
1022-1035[CrossRef][Medline]
[Order article via Infotrieve]
|
| 63.
|
Evans, D. R. H.,
and Stark, M. J. R.
(1997)
Genetics
145,
227-241[Abstract]
|
| 64.
|
Andrews, P. D.,
and Stark, M. J. R.
(2000)
J. Cell Sci.
113,
507-520[Abstract]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C.-S. Shin, S. Y. Kim, and W.-K. Huh
TORC1 controls degradation of the transcription factor Stp1, a key effector of the SPS amino-acid-sensing pathway in Saccharomyces cerevisiae
J. Cell Sci.,
June 15, 2009;
122(12):
2089 - 2099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Colomina, F. Ferrezuelo, H. Wang, M. Aldea, and E. Gari
Whi3, a Developmental Regulator of Budding Yeast, Binds a Large Set of mRNAs Functionally Related to the Endoplasmic Reticulum
J. Biol. Chem.,
October 17, 2008;
283(42):
28670 - 28679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Huang, J. Lu, and A. S. Bystrom
A genome-wide screen identifies genes required for formation of the wobble nucleoside 5-methoxycarbonylmethyl-2-thiouridine in Saccharomyces cerevisiae
RNA,
October 1, 2008;
14(10):
2183 - 2194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, H. Wei, T.-C. Hsieh, and D. C. Pallas
Cdc55p-Mediated E4orf4 Growth Inhibition in Saccharomyces cerevisiae Is Mediated Only in Part via the Catalytic Subunit of Protein Phosphatase 2A
J. Virol.,
April 1, 2008;
82(7):
3612 - 3623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Linderholm, C. L. Findleton, G. Kumar, Y. Hong, and L. F. Bisson
Identification of Genes Affecting Hydrogen Sulfide Formation in Saccharomyces cerevisiae
Appl. Envir. Microbiol.,
March 1, 2008;
74(5):
1418 - 1427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bermejo, E. Rodriguez, R. Garcia, J. M. Rodriguez-Pena, M. L. Rodriguez de la Concepcion, C. Rivas, P. Arias, C. Nombela, F. Posas, and J. Arroyo
The Sequential Activation of the Yeast HOG and SLT2 Pathways Is Required for Cell Survival to Cell Wall Stress
Mol. Biol. Cell,
March 1, 2008;
19(3):
1113 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Pujol-Carrion, G. Belli, E. Herrero, A. Nogues, and M. A. de la Torre-Ruiz
Glutaredoxins Grx3 and Grx4 regulate nuclear localisation of Aft1 and the oxidative stress response in Saccharomyces cerevisiae
J. Cell Sci.,
November 1, 2006;
119(21):
4554 - 4564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jiang
Regulation of the Cell Cycle by Protein Phosphatase 2A in Saccharomyces cerevisiae
Microbiol. Mol. Biol. Rev.,
June 1, 2006;
70(2):
440 - 449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Tang, J. Breger, A. Idnurm, K. J. Gerik, J. K. Lodge, J. Heitman, S. B. Calderwood, and E. Mylonakis
Cryptococcus neoformans Gene Involved in Mammalian Pathogenesis Identified by a Caenorhabditis elegans Progeny-Based Approach
Infect. Immun.,
December 1, 2005;
73(12):
8219 - 8225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Vilella, E. Herrero, J. Torres, and M. A. de la Torre-Ruiz
Pkc1 and the Upstream Elements of the Cell Integrity Pathway in Saccharomyces cerevisiae, Rom2 and Mtl1, Are Required for Cellular Responses to Oxidative Stress
J. Biol. Chem.,
March 11, 2005;
280(10):
9149 - 9159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wang, S. Vavassori, L. M. Schweizer, and M. Schweizer
Impaired PRPP-synthesizing capacity compromises cell integrity signalling in Saccharomyces cerevisiae
Microbiology,
October 1, 2004;
150(10):
3327 - 3339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Reinke, S. Anderson, J. M. McCaffery, J. Yates III, S. Aronova, S. Chu, S. Fairclough, C. Iverson, K. P. Wedaman, and T. Powers
TOR Complex 1 Includes a Novel Component, Tco89p (YPL180w), and Cooperates with Ssd1p to Maintain Cellular Integrity in Saccharomyces cerevisiae
J. Biol. Chem.,
April 9, 2004;
279(15):
14752 - 14762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Jablonowski, L. Fichtner, M. J.R. Stark, and R. Schaffrath
The Yeast Elongator Histone Acetylase Requires Sit4-dependent Dephosphorylation for Toxin-Target Capacity
Mol. Biol. Cell,
March 1, 2004;
15(3):
1459 - 1469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Garcia-Gimeno, I. Munoz, J. Arino, and P. Sanz
Molecular Characterization of Ypi1, a Novel Saccharomyces cerevisiae Type 1 Protein Phosphatase Inhibitor
J. Biol. Chem.,
November 28, 2003;
278(48):
47744 - 47752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Torres, C. J. Di Como, E. Herrero, and M. A. de la Torre-Ruiz
Regulation of the Cell Integrity Pathway by Rapamycin-sensitive TOR Function in Budding Yeast
J. Biol. Chem.,
November 1, 2002;
277(45):
43495 - 43504.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|